Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple oral and poster presentations, ...

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nano-PFA or nsPFAtm) technology, today announced plans to present at the upcoming TD Cowen ...

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Opteon growth, cost-saving victories, and 2025 forecasts. Learn about key trends shaping the company's future.

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Michael Carrel; President, Chief Executive Officer, Director; AtriCure Inc. Angela Wirick; Chief Financial Officer; ...

Chelsea's Premier League Community Captain honoured for his support for other participants on the club's Cancer ...

“Overall, these survey findings show that PFA use is accelerating faster than expected a year ago,” the BTIG analysts wrote in a report Monday. The survey, conducted in mid-January, also suggests PFA ...

But behind every memorable presentation is a set of carefully crafted techniques that the best speakers use to hold their audience’s attention. While you’ve probably heard the standard advice ...

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland, Feb. 18, 2025 /PRNewswire/ ...